FDA Investigator David Perkins

David Perkins has conducted inspections on 47 sites in 4 countries as of 07 May 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
47
Last Inspection Date:
07 May 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Norway, Switzerland
FDA Investigators that have inspected at least one site in common with David Perkins:
Ademola O Daramola, Aditi S Thakur, Alan M Barker, Alan M Roberts, Alberto A Viciedo, Alecia L Marson, Alice S Tsao, Alicia M Mozzachio, Amanda S Zorn, Ana E Morales, Ana L Kewes, Anastasia M Shields, Andrew A Leboeuf, Andrew F Shrake, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Anthony R Petriella, Anthony R Ronga, Arsen Karapetyan, Ashar P Parikh, Ashley L Reiber, Azza Talaat, Barbara M Frazier, Barry Cherney, PhD, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Carl A Huffman, III, Carlyn L Ray, Carmen M Faraianu, Carol L Rehkopf, Caroline H Le, Carrie Ann Plucinski, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charles L Zhou, Cheryl A Fuhs, Cheryl M Monroe, Christian D Lynch (CDL), Christina A Miller, Christina V Santos, Christopher B Harding, Christopher D Leach, Claire M Minden, Constantin Y Philopoulos, Corrine M Carter, Daniel J Brown, Dariusz Galezowski, Darrell E Luedtke, Darren S Morgan, David J Gasparovich, Deborah M Trout, Debra I Love, Denise L Burosh, Denise M Digiulio, Don H Bark, PhD, Dr. Gang Wang, PhD, Eboni S Funderburk, Eliezar Ramos, Elizabeth L Philpy, Emily J Orban, Eric M Mueller, PharmD, Eric S Pittman, Gale E Ryan, Gene D Arcy, Geneve M Maxwell, Gregory Price, Gregory R Dill, Howard Sklamberg, Humera T Khan, Jacob G Lutz, Jacqueline Mdiaz Albertini, James W Plucinski, Janae D Price, Jason F Chancey, Jeanne J Chiu, Jeanne M Morris, Jeffrey D Meng, Jennifer A D'angelo, Jennifer A Kemp, Jennifer L Schmidt, Jesse A Vazquez, Joan A Loreng, Jocelyn C Turner, John Godshalk, John M Seale, Jose Acruz Gonzalez, Joseph A Morkunas, Joseph A Piechocki, Joshua M Adams, Joshua P Wireman, Justin A Boyd, Karen Emasley Joseph, Kellia N Hicks, Kerry L Edwards, III, Kristen D Jarell, Kristen E Szenderski, Kshitij A Patkar, Kyran R Gibson, Lana K Waselewski, Larry F Hallberg, Latoya A Griffith, Laura Fontan, MS, Laurel A Beer, Laurie A Haxel, LCDR Debra Emerson, LCDR Randall L Morris, Lequita M Mayhew, Leslie A Paul, Liliya V Bubiy, Linda F Murphy, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Maksim A Levenchuk, Margaret Torres Vazquez, Mark E Frank, Mark G Peterson, Mark I Kaspar, Marlene G Swider, Martha Sullivan Myrick, Martin K Yau, PhD, Michael D Robinson, Michael J Nerz, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Micmarie Ramos Rodriguez, Mihaly S Ligmond, Mra Mcculloughj, Natasha R Johnson, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Niketa Patel, Norman K Starks, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick C Klotzbuecher, Patsy J Domingo, Paul M Kawamoto, Paula A Trost, Paula P Demichael, Pete Amin (Pankaj), Phung Thien Nguyen, Prabhu P Raju, Rabin N Ghoshal, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Richard H Penta, Richard Heath Coats, Richard T Riggie, Robert D Tollefsen, Roberta W Cunningham, Rona Leblanc, PhD, Rose Ashley, Rosemary Wood Sexton, Ross J Grigsby, Russ R Rivy, Russell K Riley, Samina S Khan, Samuel A Hamblin, Samuel W Labinjo, Sandra A Boyd, Sandra A Hughes, Santos E Camara, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Shafiq S Ahadi, Simone E Pitts, Stacie A Woods, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Sullan, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Tamara Brey, That Q Dang, Thomas J Arista, Todd M Stankewicz, Tonia F Bernard, Tracey Asinjen Wiersma, Unnee Ranjan, Vaishali J Patel, Vioela J Caze, William D Tingley, William G Nelson, William R Weissinger, Yonggang Wang, PhD, Yvonne E Lozano, Zachary A Bogorad, Zerita White, Zhongren Wu

David Perkins's Documents

Publish Date Document Type Title
August, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-08-16
June, 2002 EIR PENN PHARMACEUTICAL SERVICES LIMITED - EIR, 2002-06-28
March, 2003 FDA 483 Response AbbVie Inc. - Form 483R, 2003-04-17
January, 2001 FDA 483 Response SGS North America Inc. - Form 483R, 2001-01-24
March, 2002 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2002-03-08
August, 2002 EIR AndersonBrecon Inc. - EIR, 2002-08-06
April, 2002 EIR Abbott Laboratories - EIR, 2002-04-03
April, 2002 FDA 483 Abbott Laboratories - Form 483, 2002-04-03
March, 2003 EIR AbbVie Inc. - EIR, 2003-03-28
April, 2002 FDA 483 Response Abbott Laboratories - Form 483R, 2002-04-18
January, 2001 FDA 483 SGS North America Inc. - Form 483, 2001-01-05
April, 2002 FDA 483 Baxter Healthcare Corporation - Form 483, 2002-02-11
April, 2001 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2001-04-23
February, 2001 EIR Toxicology Research Lab/UIC - EIR, 2001-02-07
May, 2003 EIR A-S Medication Solutions LLC - EIR, 2003-05-02
February, 2001 FDA 483 Response Toxicology Research Lab/UIC - Form 483R, 2001-03-12
May, 2001 FDA 483 CSL Behring L.L.C. - Form 483, 2001-05-24
March, 2002 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2002-03-08
September, 2002 FDA 483 Response AbbVie Inc. - Form 483R, 2002-10-04
January, 2001 EIR SGS North America Inc. - EIR, 2001-01-05
June, 2002 FDA 483 CSL Behring L.L.C. - Form 483, 2002-06-06
August, 2002 EIR ANDERSONBRECON INC. - EIR, 2002-08-07
August, 2001 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2001-09-07
June, 2002 EIR CSL Behring L.L.C. - EIR, 2002-06-06
May, 2001 EIR CSL Behring L.L.C. - EIR, 2001-05-24
May, 2000 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2000-05-04
July, 2000 FDA 483 L. Perrigo Company - Form 483, 2000-07-14
April, 2002 EIR Steris Isomedix Services - EIR, 2002-04-25
March, 2003 FDA 483 AbbVie Inc. - Form 483, 2003-03-28
June, 2000 EIR AbbVie Inc. - EIR, 2000-06-19
December, 2002 EIR American Blending & Filling Company, Inc. - EIR, 2002-12-03
September, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-09-20
October, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-10-19
March, 2002 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2002-09-03
May, 2000 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2000-05-04
April, 2002 EIR Baxter Healthcare Corporation - EIR, 2002-02-11
April, 2001 EIR Baxter Healthcare Corporation - EIR, 2001-04-13
August, 2002 EIR AndersonBrecon, Inc. d.b.a. PCI of Illinois - EIR, 2002-08-05
February, 2001 FDA 483 Toxicology Research Lab/UIC - Form 483, 2001-02-07
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-03-01
May, 2000 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2000-05-22
July, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-07-20
June, 2002 FDA 483 Penn Pharmaceutical Services Limited - Form 483, 2002-06-28
December, 2002 FDA 483 American Blending & Filling Company, Inc. - Form 483, 2002-12-03
April, 2001 FDA 483 Baxter Healthcare Corporation - Form 483, 2001-04-13
March, 2001 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2001-03-01
September, 2002 EIR AbbVie Inc. - EIR, 2002-09-20
June, 2002 FDA 483 Response PENN PHARMACEUTICAL SERVICES LIMITED - Form 483R, 2002-07-11
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-04-12
March, 2001 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2001-03-01
October, 2000 EIR Precision Dose Inc. - EIR, 2000-10-05
March, 2001 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2001-03-23
May, 2003 FDA 483 A-S Medication Solutions LLC - Form 483, 2003-05-02
June, 2002 FDA 483 Response CSL Behring L.L.C. - Form 483R, 2002-08-21
August, 2001 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2001-08-16
July, 2001 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2001-07-20
August, 2002 EIR ANDERSONBRECON INC. - EIR, 2002-08-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more